ACM Research, Inc. ($ACMR) reported a 40% year-over-year growth for 2024, driven by accelerated domestic substitution. The company highlighted the potential value of its listed Shanghai asset, which is believed to be worth multiples of the current stock price. Additionally, the IPO lockup period has ended, opening up various monetization opportunities for the firm. Following these developments, $ACMR shares experienced a pre-market increase of 14.9% and have risen as much as 63% since a bullish recommendation by Kerrisdale Capital. The stock's momentum is further evidenced by the trading of 4000 March $30 call options, indicating investor interest in the company's prospects.